Available technology
Our commercialisation experts can connect you with intellectual property from the world-class researchers at the University of Adelaide. We have a range of technologies available for licensing and investment.
The following provides a sample of our technology. Please contact our Commercialisation team to discuss our full range of projects.
Superconducting magnetic sensor
A next-generation high-sensitivity and high-resolution superconducting magnetic sensor for medical applications.
Commercial contact: Aisha Sirop
Automated Cardiac Beat-to-Beat Variability Monitoring
A fully automated ECG processing technology that also includes conventional fiducial wave delineation, providing unprecedented accuracy in beat-to-beat measurement of the QT interval, significantly outperforming existing methods.
Commercial contact: Aisha Sirop
Hybrid Imaging Catheter
A new multi-modal optical coherence tomography (OCT) and autofluorescence imaging technology.
Commercial contact: Aisha Sirop
Structural Health Monitoring System
A low-cost, multichannel early warning active structural health monitoring system using piezoelectric sensors.
Commercial contact: Aisha Sirop
GLAS Technology
A method of glass production which creates a wide range of colour codes and dichroic colour effect.
Commercial contact: Francois Duvenage
Zinc Acid Manganese Battery
A zinc acid manganese (ZAM) battery that has more than double the energy density of comparable batteries.
Commercial contact: Gerard LaFontaine
Apicomplexan Vaccine
A non-live vaccine for the prevention of Apicomplexan parasitic diseases and pathogens.
Commercial contact: Francois Duvenage
Antiviral Agents
A proposal to screen several naturally occuring nucleoside analogues and their derivatives for antiviral activity.
Commercial contact: Dr JC Tan
Easy Peel Tomato
The first self-peeling tomato for faster, lower cost processing.
Commercial contact: Cathryn Lee
Zika Virus NS1 DNA Vaccine
A plasmid DNA vaccine that encodes a secreted form of Non-Structural Protein 1.
Commercial contact: Dr JC Tan
Novel Antibiotics Based on Biotin Protein Ligase Inhibition
A new antibiotic that successfully targets infections based on Biotin Protein Ligase (BPL) inhibition.
Commercial contact: Dr JC Tan
A New Naive Embryonic Stem Cell
A new naive embryonic stem cell with increased pluripotency, and enhanced differentiation capacity, for treating neurological conditions.
Commercial contact: Dr JC Tan
Hydrogen-Bonded Organic Frameworks as Protective Coatings for Biomolecules
A purely organic, chrystalline matrix that can encapsulate, protect and preserve bio-molecules such as proteins, vaccines and enzymes.
Commercial contact: Dr JC Tan
New Australian Psyllium
An all-natural gelling agent for use in gluten-free processed food markets as a next generation dietary fibre.
Commercial contact: Cathryn Lee
Photocatalytic Conversion of CO2
A solar-induced system for photocatalytic conversion of carbon dioxide and water into fuel.
Commercial contact: Francois Duvenage
Method & System to Detect Orbiting Objects
Robust foreground segmentation and image registration for optical detection of objects in geostationary orbit.
Commercial contact: Francois Duvenage
Contact us
To be connected with one of our Commercial Managers contact us on:
T: +61 8 8313 1336 or E: commercialisation@adelaide.edu.au